Does histocompatibility affect homograft valve function after the Ross procedure?

Circulation

Volumn 104, Issue SUPPL. 1, 2001, Pages

  Bechtel, J F M ^a   Bartels, C ^a   Schmidtke, C ^a   Skibba, W ^a   Muller Steinhardt M ^a   Kluter H ^a   Sievers, H H ^a  

^a Klinik fur Herzchirurgie   (Germany)

Author keywords

Immunology; Surgery; Transplantation; Valves

Indexed keywords

ADULT; ALLOGRAFT; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; MALE; PRIORITY JOURNAL; PULMONARY VALVE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0035909023     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc37t1.094899     Document Type: Article

References (25)

1. The Ross procedure: Current registry results
2. Up to seven years of experience with the Ross procedure in patients >60 years of age
3. Pulmonary autograft versus aortic homograft for aortic valve replacement: Interim results from a prospective randomized trial
4. Evaluation of cryopreserved homografts in the fight ventricular outflow tract after the Ross procedure intermediate-term follow-up
5. Rest and exercise hemodynamics after the Ross procedure: An echocardiographic study
6. Echocardiographic follow-up after Ross procedure in 100 patients
7. Donor-specific cellular immune response against human cardiac valve allografts
8. Human name valve allografts elicit a donor-specific immune response
9. Serotyping for homotransplantation by the microdroplet lymphocyte cytotoxicity test
10. Size and distensibility of the aortic root and aortic valve function after different techniques of the Ross procedure
11. Pulmonary autograft in children: Realized growth potential
12. Pathology of explanted cryopreserved allograft hem valves: Comparison with aortic valves from orthotopic heart transplants
13. Pulmonary autograft reoperation: Incidence and management
14. Evidence for rejection of homograft cardiac valves in infants
15. The aortic valve after heart transplantation
16. Cryopreserved aortic homografts contain viable smooth muscle cells capable of expressing transplanlation antigens
17. Influence of HLA matching and associated factors on aortic valve homograft function
18. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching
19. Effect of cryopreservation and HLA-DR matching on the cellular immurogenicity of human cardiac valve allografts
20. Effect of antihiotic pretreatment on immunogenicity of human heart valves and component cells
21. The role of anti-HLA antibodies in heart transplantation
22. Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance
23. Lack of ABH-antigen expression on human cardiac valves
24. Anti-HLA class I antibodies and pulmonary homograft function after the Ross procedure
25. Persistence of human leukocyte antigen (HLA) antibodies after one year in children receiving cryopreserved valved allografts